We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

138 hedge funds and large institutions have $430M invested in Voyager Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,285% more call options, than puts

Call options by funds: $830K | Put options by funds: $13K

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

18% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 40

5% more funds holding

Funds holding: 131 → 138 (+7)

0.17% more ownership

Funds ownership: 83.06% → 83.23% (+0.17%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

19% less capital invested

Capital invested by funds: $528M → $430M (-$98M)

Holders
138
Holders Change
+7
Holders Change %
+5.34%
% of All Funds
2.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
47
Reduced
40
Closed
18
Calls
$830K
Puts
$13K
Net Calls
+$817K
Net Calls Change
-$839K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$7.67M
2
Millennium Management
Millennium Management
New York
+$7.16M
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$6.65M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.71M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$4.13M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$21.2M
2
BC
Boxer Capital
California
-$8.61M
3
Invesco
Invesco
Georgia
-$4.56M
4
ClearBridge Investments
ClearBridge Investments
New York
-$3.29M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
KPW
126
Kore Private Wealth
New York
$10K +$10.9K +750 New
CG
127
Cutler Group
California
$6K +$1.45K +100 +25%
WEC
128
Winslow Evans & Crocker
Massachusetts
$4K – – –
Daiwa Securities Group
129
Daiwa Securities Group
Japan
$3K – – –
MAM
130
Meeder Asset Management
Ohio
$2K -$94.3K -6,485 -97%
IA
131
IFP Advisors
Florida
$2K – – –
PCM
132
Prelude Capital Management
New York
$2K +$567 +39 +36%
AG
133
Advisor Group
Arizona
$2K +$1.73K +119 New
GEA
134
Glen Eagle Advisors
New Jersey
$1.4K – – –
AssetMark Inc
135
AssetMark Inc
California
$1K – – –
CFA
136
Carroll Financial Associates
North Carolina
$1K – – –
OIA
137
Optimum Investment Advisors
Illinois
$1K – – –
SFS
138
Sowell Financial Services
Arkansas
$1K – – –
PHS
139
PFM Health Sciences
California
– -$21.2M -1,231,954 Closed
BC
140
Boxer Capital
California
– -$8.61M -500,000 Closed
3C
141
361 Capital
Colorado
– -$2.07M -120,143 Closed
WCM
142
Weld Capital Management
New York
– -$782K -45,463 Closed
OAM
143
Oxford Asset Management
United Kingdom
– -$741K -43,067 Closed
Marshall Wace
144
Marshall Wace
United Kingdom
– -$725K -42,141 Closed
HIM
145
Hillsdale Investment Management
Ontario, Canada
– -$637K -37,000 Closed
TAM
146
Tocqueville Asset Management
New York
– -$493K -28,655 Closed
Jane Street
147
Jane Street
New York
– -$212K -12,302 Closed
PIM
148
Partner Investment Management
California
– -$196K -11,378 Closed
CIP
149
Convergence Investment Partners
Florida
– -$92K -5,337 Closed
QT
150
Quantbot Technologies
New York
– -$73K -4,295 Closed
3 4 5
6
7

VYGR Hedge Fund Activity: Q4 2019 in Review

138 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q4 2019, worth a combined $430M — down 19% from $528M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new VYGR positions and 18 closed out — a net gain of 8 holders — while 47 added to existing stakes and 40 trimmed.

The largest buyer was Armistice Capital, adding an estimated $7.67M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $21.2M sold.

  • 138 institutional investors held Voyager Therapeutics (VYGR) as of Q4 2019, up from 131 in Q3 2019.
  • Funds reported $430M of Voyager Therapeutics stock for Q4 2019, down 19% quarter-over-quarter.
  • 26 funds opened new Voyager Therapeutics positions in Q4 2019 and 18 closed out, a net change of +8 holders.
  • The largest Voyager Therapeutics buyer in Q4 2019 was Armistice Capital, an estimated $7.67M added.
  • The largest Voyager Therapeutics seller in Q4 2019 was PFM Health Sciences, an estimated $21.2M sold.

Based on aggregated 13F filings for Q4 2019.